- KR₩439bn
- KR₩520bn
- KR₩247bn
Brief: Medy Tox To Buy 5 Billion Won Treasury Shares
Brief: Medy Tox Q1 Operating. Profit 7.3 Billion Won, Rising 35% Y/Y
Brief: Medy Tox To Acquire 5 Billion Won Worth Of Own Shares
Brief: Medy-Tox To Acquire 3 Billion Won Worth Of Own Shares
Brief: Medy-Tox Inc Q3 Operating Profit 9 Billion Won, Up 48.3% From Year Earlier
Brief: Medy-Tox Q2 Operating Profit 6.3 Billion Won, Down 56% From Year Earlier
Brief: Medy-Tox Q1 Operating Profit 5.5 Billion Won, Swings To Profit From Year Earlier
Brief: Medy-Tox To Acquire 5 Billion Won Worth Of Own Shares
Brief: Medy-Tox To Acquire 5 Billion Won Worth Of Own Shares
Brief: Medy-Tox To Acquire 4 Billion Won Worth Of Own Shares
Brief: Medy-Tox Q3 Operating Profit 6 Billion Won, Up 68% From Year Earlier
Brief: Medy-Tox To Acquire 3 Billion Won Worth Of Own Shares
Brief: Medy-Tox Q2 Operating Profit 14.3 Billion Won, Up 50% From Year Earlier
Brief: Medy-Tox Inc Q1 Operating Loss 930 Million Won
Brief: Medy-Tox Q3 Operating Profit 3.6 Billion Won, Down 75.4% From Year Earlier
Brief: Medy-Tox Inc Q2 Operating Profit 9.6 Billion Won, Down 8% From Year Earlier
Brief: Medy-Tox To Divest 18.5 Billion Won Worth Of Own Shares
Brief: Medy Tox Inc To Sell 23 Billion Won Worth Of Shares In Evolus Inc
Brief: Medy Tox Inc Q3 Operating Profit 14.5 Billion Won, Down 57% From Year Earlier